| CORRESPONDING AUTHOR |
E-MAIL |
TITLE |
| Abel, Frida |
 |
Imbalance of transcripts encoding mitochondrial pro- and anti-apoptotic members in unfavorable neuroblastoma |
| Alaminos, Miguel |
|
EMP3, A Putative Tumor Suppressor Gene Mapping At 19q13.3, Is Epigenetically Silenced In Neuroblastoma By Promoter Hypermethylation and May Have Prognostic Value |
| Alaminos, Miguel |
|
A clustering of gene hypermethylation distinguishes high and low-risk neuroblastoma patients |
| Amato, Ilaria |
|
Biological modifiers of RANKL activity prevents osteoclastogenesis induced by neuroblastoma cells |
| Ambros, Inge |
|
Senescent F-cells - from oncogene amplification to cellular senescence |
| Ambros, Peter F |
|
Unequivocal Identification of Disseminated Tumor Cells in the Bone Marrow by Immunofluorescence and FISH reveal essential Functional and Prognostic Information |
| Ambros, Peter F |
|
Expression profiling of aggressive and benign neuroblastic tumors: is there a common pattern? |
| Angelini, Paola |
|
Ganglioneuroma in childhood: the Italian experience with 127 cases |
| Angelini, Paola |
|
Spinal cord compression (SCC) in neuroblastoma: the Italian experience from 1999-2003 |
| Angelini, Paola |
|
Skeletal involvement in infants with neuroblastoma. A quality control attempt. |
| Aoyama, Mineyoshi |
|
LIM-only protein, LMO3, is up-regulated and acts as an oncogene in aggressive neuroblastomas by physically interacting with a neuronal bHLH transcription factor, HEN2 |
| Armstrong, Jane |
|
Effect of R116010 on Retinoic Acid Metabolism and Action in Neuroblastoma |
| Asgharzadeh, Shahab |
|
Microarray Expression Profiling Improves Definition of High- and Intermediate-Risk Metastatic Neuroblastomas without MYCN Amplification |
| Ash, Shrifa |
|
13 cis- retinoic acid in children with high-risk neuroblastoma: Is more better? |
| Atsuko, Nakagawa |
|
TrkA Expression in Peripheral Neuroblastic Tumors: Prognostic Significance and Biological Relevance |
| Avigad, Smadar |
|
Telomere length - as a prognostic marker in neuroblastoma |
| Azarbayjani, Faranak |
|
Digoxin inhibits neuroblastoma tumor growth in mice |
| Bachmann, Andre |
|
Polyamine Biosynthetic Pathway as a Drug Target for neuroblastoma Therapy |
| Balwierz, Walentyna |
|
Spinal Cord Compression in Neuroblastoma- Experience of Polish Pediatric Solid Tumors Study Group (PPSTSG) |
| Balwierz, Walentyna |
|
Central nervous system (CNS) involvement in children with neuroblastoma (NBL) at the diagnosis and in relapse |
| Baruchel, Sylvain |
|
Ursolic Acid decreases hypoxia-mediated resistant to apoptosis in SK-N-B2 neuroblastoma cell lines by upregulating caspase-3 activity and downregulating VEGF secretion |
| Battistelli, Luca |
|
Serum levels of sRANKL and OPG in patients with neuroblastoma |
| Begent, Joanna |
|
Spinal Neuroblastoma in Stage 2/3 Disease – Experience From One Institution |
| Bell, Emma |
|
The role of MYCN amplification in the p53 response to DNA damage |
| Berthold, Frank |
|
From genotype to phenotype in neuroblastoma: The derivation of clinically different entities |
| Bestagno, Marco |
|
Production of dimeric small immunoproteins specific for neuroblastoma-associated antigen GD2 |
| Betts, David |
|
High-hyperdiploidy, an overlooked sub-group in neuroblastoma |
| Biagiotti, Tiziana |
|
On the search of neuroblastoma stem cell compartment: electrophysiological and immunocytochemical studies |
| Bilke, Sven |
|
Phylogeny of Neuroblastoma Tumor Progression from Comparative Genomic Hybridization Data |
| Blaes, Franz |
|
Immunopathogenesis of Opsoclonus-Myoclonus-Syndrome |
| Boensch, Marc |
|
Quantitative Real-Time PCR for the simultaneous determination of prognostic markers MYCN amplification, deletion 1p and 11q |
| Bogenmann, Emil |
|
Neuroblastoma Differentiation is Regulated by the Cooperation of the RET and TRKA Signaling Pathways |
| Boni, Luca |
|
Influence of age on stage 4 neuroblastoma |
| Borgström, Per |
|
The use of liposomal busulphan in high-dose therapy of neuroblastoma |
| Bosco, Maria Carla |
|
Flavopiridol induces cell cycle arrest and apoptosis in human neuroblastoma cells. Enhancement by hypoxia and correlation with MYCN inhibition |
| Bourdeaut, Franck |
|
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in hereditary neuroblastoma. |
| Bozzi, Fabio |
|
Bone marrow infiltration in neuroblastoma: a flow cytometric tri-colour assay |
| Brignole, Chiara |
|
Anti-tumour effects of anti-GD2-targeted liposomal antisense oligonucleotides result from a CpG-mediated immune stimulatory effect synergising with an anti-c-myb effect |
| Brodeur, Garrett |
|
Functional and Expression Analysis of CHD5, a Candidate Neuroblastoma Suppressor on 1p36 |
| Bruchelt, Gernot |
|
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic (stem) cells |
| Burchill, Sue |
|
Quality assurance of reverse transcriptase polymerase chain reaction (RT-PCR) to detect neuroblastoma: ESIOP Neuroblastoma Group |
| Calvet, Loreley |
|
In vivo resistance to CPT-11 in neuroblastoma: Does pleiotrophin play a role? |
| Campostrini, Natascia |
|
Proteomic analysis of an orthotopic neuroblastoma animal model |
| Cañete, Adela |
|
Comparison of two induction regimens for high-risk neuroblastoma |
| Carén, Helena |
|
Methylation studies of genes located in the chromosome region 1p36.2 in neuroblastoma tumors |
| Carr, Jane |
|
Selection for p53 mutant cells by cytotoxic agents in neuroblastoma |
| Castagnola, Elio |
|
Neutropenia and fever in children with neuroblastoma treated with the European High-Risk Protocol. A mono-institutional experience |
| Castellani, Maria Rita |
|
Assessment of chemotherapy response by MIBG scan: a blind quality control |
| Castelli, Chiara |
|
Antigen specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen |
| Castle, Valerie |
|
p53/MEK1/NF-kappaB Signaling Pathway Mediates Anticancer Drugs Induced Cell Death in N-type Neuroblastoma Cells |
| Castle, Valerie |
|
Chemotherapy Induced S-Type Cell Death Via A Caspase-9 Dependant, p53 Independent Mechanism |
| Castriconi, Roberta |
|
Analysis of susceptibility of Neuroblastoma to NK-mediated killing and identification of a novel cell surface antigen expressed by Neuroblastoma |
| Cecchetto, Giovanni |
|
The importance of Surgical Risk Factors (SRF) in primary surgery for localized neuroblastoma (NBL): results of LNESG I Study |
| Cenacchi, Nicola |
|
Induction of the BH3-only HRK and BBC3 Correlates with Sensitivity to Fenretinide in Neuroblastoma Cell Lines |
| Cesi, Vincenzo |
|
IGFBP-5 in neuroblastoma: complex regulations and multiple effects. |
| Chan, Godfrey CF |
|
Safety and Systemic Availability of Intravenous and Oral Arsenic Trioxide (As2O3) in Children with Relapsed / Refractory Neuroblastoma |
| Chang, Christina L. |
|
Nucleoside diphosphate kinase A/NM23-H1 is a metastasis promoter and not a suppressor in human neuroblastoma |
| Chen, Qingrong |
|
Probabilistic Analysis of cDNA Array-CGH Profiles Identifies Genomic Alterations Specific to Stage and MYCN-Amplification in Neuroblastoma |
| Chen, Yuyan |
|
Expression of the PPM1D gene is associated with poor prognosis in Neuroblastoma |
| Chesler, Louis |
|
Small molecule inhibitors of PI3-Kinase suppress growth of neuroblastoma cell lines by destabilizing Mycn protein |
| Cheung, Belamy |
|
The estrogen-responsive B box protein: a novel co-activator of tumor suppressor gene RARbeta in neuroblastoma |
| Cheung, Irene |
|
Measuring circulating neuroblastoma cells by quantitive RT-PCR: correlation with paired bone marrow and standard disease markers |
| Cheung, Nai-Kong |
|
Early use of anti-GD2 antibody 3F8 plus reduction from 7 to 5 cycles of dose-intensive induction chemotherapy can improve molecular response in high-risk neuroblastoma (NB) |
| Chiesa, Carlo |
|
Dosimetry in 131I-MIBG mieloablative therapy |
| Coco, Simona |
|
LOH analysis on microdissected neuroblastic cells reveals undetected interstitial deletions at chromosome 1p36 in neuroblastoma |
| Cohn, Susan |
|
Inhibition of Angiogenesis by the Epidermal Growth Factor (EGF)-module of the Follistatin Domain of SPARC is Conformation-Dependent |
| Combaret, Valérie |
|
Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients: Results of a blind multicentric study |
| Combaret, Valérie |
|
Discrimination between good and bad prognosis neuroblastoma by serum protein expression profiles analysis |
| Combaret, Valérie |
|
Genome-wide analysis of gene expression in neuroblastomas detected by mass screening |
| Conte, Massimo |
|
Malignant Neuroblastic Tumors (NTs) in the Adolescent (10-18 y). The Italian Experience with 51 Cases |
| Corrias, Maria Valeria |
|
Low dose interferon-( producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity |
| Corrias, Maria Valeria |
|
Evaluation of efficacy of NK cell therapy in human neuroblastoma-bearing mice |
| Cosimo, Emilio |
|
Enhancement of targeted radiotherapy in neuroblastoma: a novel gene therapy approach |
| Croce, Michela |
|
Neuroblastoma immunotherapy with IL-12 and IL-15-gene modified NB cells |
| Das, Bikul |
|
Ursolic Acid decreases hypoxia-mediated resistant to apoptosis by upregulating caspase-3 activity and downregulating VEGF secretion in a MYCN amplified neuroblastoma cell line |
| Dau, Daniela |
|
Neuroblastoma in the Adult. A Report on 24 Cases |
| Davidoff, Andrew |
|
Interferon-mediated anti-angiogenic therapy for neuroblastoma |
| De Ambrosis, Alessandro |
|
Constitutive and IFN-inducible expression of the Caspase-8 gene in Neuroblastoma cells is regulated through an essential Interferon-Sensitive Response Element (ISRE) |
| De Bernardi, Bruno |
|
Metastaic/multifocal neuroblastoma in the first year of life |
| De Geer, Anna |
|
Cytotoxic T lymphocytes activated on third party targets induce cell death in neuroblastomas in a MHC-independent fashion |
| De Lagausie, Pascal |
|
Laparoscopic adrenal surgery for neuroblastomas in children |
| De Preter, Katleen |
|
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons |
| De Preter, Katleen |
|
A putative haplo-insufficient contribution of SDHD to high stage neuroblastoma tumorigenesis |
| De Preter, Katleen |
|
Isolation of normal neuroblastoma precursor cells: tools for comparative gene expression profiling |
| DeClerck, Yves |
|
Bone Marrow Derived Matrix Metalloproteinase-9 Regulates Maturation of Neuroblastoma Vasculature |
| DeClerck, Yves |
|
Bone Marrow Mesenchymal Stem Cells are Essential for Osteoclast Activation in Bone Invasion by Human Neuroblastoma |
| DeClerck, Yves |
|
Combination therapy of zoledronate and low-dose cyclophosphamide improves survival in a xenograft model of bone invasion in neuroblastoma |
| DeClerck, Yves |
|
Absence of plasminogen activator inhibitor-1 inhibits angiogenesis and progression in neuroblastoma |
| Desai, Sunil |
|
A single institution study of low dose 1311mIBG therapy for stage 4 neuroblastoma – therapeutic implications |
| Di Francesco, Angela Maria |
|
The novel 7-substitued camptothecin analog ST1481 (GIMATECAN) is active in preclinical models of human neuroblastoma |
| Djurisic, Marina |
|
Our experience with diagnosis of neuroblastoma using cytogenetic, molecular cytigenetic and molecular techniques |
| Domenicotti, Cinzia |
|
Protein kinase C isoforms and glutathione levels: a molecular switch between proliferation and apoptosis in human neuroblastoma cells |
| Dominici, Carlo |
|
c-KIT expression identifies a subset of aggressive neuroblastomas |
| Dominici, Carlo |
|
Therapeutic activity of STI571 in neuroblastoma xenografts |
| Douc-Rasy, Sétha |
|
The neurogene BTG2 is transactivated by DeltaNp73alpha via p53 in neuroblastoma cell lines |
| Douc-Rasy, Sétha |
|
cDNA macroarrays analyses of p73-target genes reveal that Wnt8A is up-regulated by DeltaN-p73 in SH-SY5Y cells |
| Douc-Rasy, Sétha |
|
Characterization of p53 mutation in neuroblastoma cell lines |
| Drozynska, Elzbieta |
|
Proliferative activity in relationships with established prognostic factors in neuroblastoma |
| Eckschlager, Tomas |
|
Effect of BS RNASE on chemo resistant neuroblastoma cell lines |
| Eggert, Angelika |
|
Application of Proteomics to Identify Novel Targets of Trk-Signaling in Neuroblastoma Cells |
| Ejeskär, Katarina |
|
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces massive cell death |
| Ernestus, Karen |
|
Expression of the therapy relevant makers EGF receptor, PDGF receptor and c-Kit in neuroblastoma determined with a multitissue array |
| Fest, Stefan |
|
Anti-neuroblastoma immunotherapy with GD2 Peptide Mimotope DNA Vaccines |
| Fischer, Matthias |
|
Identification of a gene signature discriminating stage 4S and stage 4 neuroblastoma using Serial Analysis of Gene Expression |
| Fix, Ann |
|
Characterization of amplicons in neuroblastoma cell lines and tumours by microarray-based comparative genomic hybridization |
| Flægstad, Trond |
|
Silencing of MYCN expression in human neuroblastoma cell lines |
| Flægstad, Trond |
|
Internalization and mitochondria targeting are involved in the cytotoxic activity against MYCN-amplified neuroblastoma cells by the petide LfcinB |
| Flahaut, Marjorie |
|
Induced doxorubicin resistance in caspase-8/10 silenced neuroblastoma cell lines results in multi-drug resistance that involves early and p53-independent anti-apoptotic mechanisms |
| Flux, Glenn |
|
Whole-body and tumour dosimetry for I-131 mIBG for neuroblastoma |
| Flux, Glenn |
|
Standardised reporting of I-123 mIBG scans for determination of response to induction chemotherapy |
| Fredlund, Erik |
|
Global gene-expression analysis in hypoxic neuroblastoma cells |
| Fulda, Simone |
|
Smac agonists as novel therapeutics to overcome resistance of neuroblastoma cells against radiation therapy |
| Fulda, Simone |
|
Resveratrol, a novel survivin antagonist: sensitization of neuroblastoma cells for TRAIL- or anticancer drug-induced apoptosis through cell cycle-mediated survivin depletion |
| Gallego, Soledad |
|
Tyrosine Hydroxylase expression in blood of patients with Neuroblastoma: Analysis by a real time RT-PCR quantitative assay |
| Gaze, Mark |
|
Intensive Targeted Chemoradiotherapy Of Metastatic Neuroblastoma With High-Dose Iodine-131 Labelled Meta-Iodobenzylguanidine, Topotecan And Haemopoietic Support |
| Geerts, Dirk |
|
MEIS1 functions as a neuroblastoma oncogene |
| Geli, Janos |
|
Frequent transcriptional silencing of RASSF5 (NORE1A) in human pheochromocytomas and neuroblastomas |
| Giannini, Giuseppe |
|
The protoncogene HMGA1 is a molecular target for MYCN in neuroblastoma |
| Goranov, Bojidar |
|
Morphological cell variants in the SH-SY5Y cell populations |
| Gotoh, Takahiro |
|
Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative PCR |
| Grandinetti, Kathryn |
|
The neuronal-specific RNA-binding protein HuD regulates MYCN expression and gene copy number in neuroblastoma cells |
| Grigoryan, Rita |
|
Cyclophosphamide, but not melphalan or carboplatin, synergistically enhanced topotecan activity against neuroblastoma cell lines in hypoxia |
| Gross, Nicole |
|
Vessel characterisation in an orthotopic model of neruoblastoma |
| Guillaud-Bataille, Marine |
|
Quantitative analysis and detailed mapping of 17q gains in neuroblastomas using array CGH |
| Haber, Michelle |
|
Association Of High-Level MRP1 Expression With Poor Clinical Outcome In A Large Prospective Study Of Primary Neuroblastoma |
| Haber, Michelle |
|
The TH-MYCN Transgenic Mouse As A Preclinical Testing Model For Neuroblastoma |
| Harris, Linda |
|
The Defective G1 Cell Cycle Checkpoint in Neuroblastoma is Mediated by the Inability of p21Waf1/Cip1 to bind to or inhibit Cyclin E-Dependent Cdk2 Kinase Activity |
| Harris, Linda |
|
p53 and JNK Apoptotic Pathways in Neuroblastoma |
| Hayashi, Kunihiko |
|
Effectiveness of mass-screening program on neuroblastoma mortality in 1995-2000 birth cohort of Japan: Nationwide Neuroblastoma Mortality Study |
| Henrich, Kai-Oliver |
|
HsCAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma |
| Hero, Barbara |
|
Observation of infants with stage 2 or stage 3 single copy MYCN neuroblastoma without chemotherapy |
| Hero, Barbara |
|
Immunosuppression with cyclophosphamide in the treatment of patients with opsomyoclonus syndrome |
| Hiyama, Eiso |
|
Gene expression profiling of neuroblastoma cell lines treated identifies genes upregulated by retinoic acid that are overexpressed in favorable neuroblastoma primary tumors |
| Ho, Ruth |
|
Epidermal Growth Factor Receptor Mediated Survival of Human Neuroblastomas |
| Hoebeeck, Jasmien |
|
Hunting for a 3p tumor suppressor gene in neuroblastoma: a combined genomic and functional approach |
| Hogarty, Michael |
|
Deregulated WNT/BCATENIN pathway in neuroblastoma without MYCN amplification |
| Hogarty, Michael |
|
BH3-domain peptidomimetics activate apoptosis and elucidate death pathways in neuroblastoma |
| Hogarty, Michael |
|
Analysis of MCL1 as a candidate oncogene within the 1Q region of gain in high-risk neuroblastomas |
| Holmquist, Linda |
|
Hypoxia induced dedifferentiation of neuroblastoma cells: phenotypic persistency after reoxygenation |
| Horwacik, Irena |
|
Isolation and Characterisation of Peptide Mimotopes of the Neuroblastoma-associated Carbohydrate Antigen GD2 Ganglioside |
| Huebener, Nicole |
|
Predicted MHC class I Epitopes deriving from Mouse Tyrosine Hydroxylase Are as Effective in DNA Vaccination Against Murine Neuroblastoma as MHC class I Ligands Naturally Expressed on Neuroblastoma Cell Surface |
| Ichikawa, Hitoshi |
|
Gene Expression Associated with Prognosis of Neuroblastoma |
| Iehara, Tomoko |
|
Infantile Dumbbell-type Neuroblastoma |
| Ilhan, Inci |
|
Cerebellar neuroblastoma in an infant |
| Imaizumi, Masue |
|
Distinct involvement of reactive oxygen species and caspase activation in apoptosis pathways in a neuroblastoma cell line, NB-39-nu, induced by retinoic acid or fenretinide |
| Inoue, Masami |
|
Double megatherapy (from auto-auto to auto-allo) for high-risk neuroblastoma |
| Jankovic, Silvija |
|
Preclinical evaluation of autologous dendritic cells transfected with tumor mRNA or loaded with apoptotic cells for immunotherapy of high risk neuroblastoma |
| Janoueix-Lerosey, Isabelle |
|
Gene expression profiling suggests a role for haploinsufficiency of 1p35-36 genes in neuroblastoma |
| Jenkner, Alessandro |
|
Front-line topotecan and high-dose cyclophosphamide followed by ICE in high-risk neuroblastoma |
| Jensen, Markus |
|
Targeting neuroblastoma with bi-specific antibodies against the neural cell adhesion molecule (NCAM) |
| Johnsen, John |
|
Cyclooxygenase-2 (COX-2) is abundantly expressed in neuroblastoma and its inhibition induces apoptosis and prevents tumour growth in vivo: implications for a novel non-toxic neuroblastoma therapy |
| Kågedal, Bertil |
|
GD2 synthase mRNA is less specific for detection of neuroblastoma in blood and bone marrow than tyrosine hydroxylase mRNA and dopadecarboxylase mRNA |
| Kaneko, Yasuhiko |
|
Neuroblastomas that might benefit from mass screening (MS) |
| Munirajan, Arasambattu Kannan |
|
KIF1B is a variant-dependent tumor suppressor gene mapped to a 500-kb homozygously deleted region at chromosome 1p36.2 in neuroblastoma |
| Karlsson, Jenny |
|
Arsenic trioxide-induced death of neuroblastoma cells involves activation of bax and does not require p53 |
| Kato, Chiaki |
|
Deregulated tyrosination/detyrosination cycle of a-tubulin, accompanied with decreased expression of human tubulin tyrosine ligase, is associated with malignant progression of neuroblastoma |
| Keshelava, Nino |
|
Genes associated with multi-drug resistance in neuroblastoma cell lines identified by gene expression profiling |
| Kikuchi, Ken |
|
Localized neuroblastoma with MYCN amplification in infants. A report of 3 cases |
| Kizyma, Zoryana |
|
A case of neuroblastoma with congenital defect of liver development in infant |
| Kogner, Per |
|
Improved outcome in high-risk neuroblastoma after application of intensified multimodal therapy |
| Koppen, Arjen |
|
Down regulation of gene-expression by N-myc in Neuroblastoma |
| Korfei, Martina |
|
Cellular distribution of autoantigens and functional activity of autoimmune sera from pediatric patients with opsoclonus-myoclonus-syndrome (OMS) |
| Kramer, Kim |
|
Favorable Biology Neuroblastoma (NB): Leptomeningeal metastases remaining stable in a child without chemoradiotherapy |
| Kramer, Kim |
|
Changing the Course of Central Nervous System (CNS) Neuroblastoma (NB)? Not with Myeloablative Chemotherapy and Peripheral Blood Stem Cell support (PBSCs) |
| Kramer, Kim |
|
Intrathecal 131-I-labeled 3F8 antibody in patients (PTS) with GD2-expressing central nervous system (CNS) and leptomeningeal (LM) neoplasms |
| Kramer, Sonja |
|
A Ran-binding protein, RanBPM, stabilizes p73 and enhances its pro-apoptotic activity: Its possible role in spontaneous regression of neuroblastoma |
| Krasnoselsky, Alexei |
|
Genome-wide micro-array analysis of neuroblastoma links genomic alterations to expression profiles |
| Kraveka, Jacqueline |
|
Involvement of Endogenous Ceramide in the Inhibition of Telomerase Activity, MYCN activity, and Induction of Morphologic Differentiation in Response to All-Trans-Retinoic Acid in Human Neuroblastoma Cells |
| Krona, Cecilia |
|
A novel 1p36.2 located gene, APITD1, with tumor suppressive properties and a putative p53 binding domain, shows low expression in neuroblastoma tumors |
| Kubota, Keiko |
|
High-dose chemotherapy consisting of thiotepa and melphalan prior to local surgery for advanced neuroblastoma |
| Kurkure, Purna |
|
Challenges in management of Advanced Neuroblastoma: Experience at Tata Memorial Hospital, Mumbai, India |
| Lacitignola, Laura |
|
Possible graft vs. neuroblastoma effect after partially matched related hematopoietic transplantation |
| Ladenstein, Ruth |
|
Risk Adapted Treatment According to the Austrian Neuroblastoma Trial A-NB94 |
| Ladenstein, Ruth |
|
The SIOPEN-R-NET Project: Building a European Network for Neuroblastoma Treatment (HR-NBL-1/ESIOP) und Research |
| Lagodny, Jeanette |
|
Studies on lymphangiogenesis in human neuroblastoma |
| Lanciotti, Marina |
|
Glutathione S-transferase polymorphism, genetic susceptibility and outcome in neuroblastoma |
| Lasorella, Anna |
|
Id2 is Sufficient and Necessary for Growth and Angiogenesis in Neuroblastoma |
| Lastowska, Maria |
|
Regions syntenic to human 17q are gained in mouse and rat neuroblastoma cell lines |
| Lau, Loretta |
|
Sensitivity of neuroblastoma cell lines to celecoxib and in combination with other chemotherapeutic agents |
| Laverdiere, Caroline |
|
Long-term complications from treatment in survivors of high risk neuroblastoma |
| Li, Zhijie |
|
Akt Pathway Mediates BDNF/TrkB Resistance to Chemotherapy in Neuroblastoma cells |
| Lindskog, Magnus |
|
Early prediction of resistance or response to chemotherapy in experimental neuroblastoma in vivo using magnetic resonance spectroscopy |
| Lipska, Beata |
|
NTRK1 gene polymorphisms in 30 primary neuroblastoma tumours |
| Liu, Shuqing |
|
Cross-talk between Schwann Cells and Neuroblasts Influences Tumor Differentiation and Angiogenesi |
| Lode, Holger |
|
Combined targeted GM/CSF and IL/2 therapy switches innate to adaptive anti-neuroblastoma immunity |
| Löfstedt, Tobias |
|
Hypoxia transcriptionally activates the ID2 gene in human neuroblastoma |
| London, Wendy B |
|
Evidence for an age cut-off higher than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group (COG) |
| Longo, Luca |
|
A novel region for predisposition to neuroblastoma maps to chromosome 12 |
| Lovat, Penny |
|
Gangliosides link fenretinide-induced ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma |
| Lovat, Penny |
|
GADD153 Mediates Apoptosis in Response to Fenretinide but Not Synergy Between Fenretinide and Chemotherapeutic Drugs in Neuroblastoma |
| Lovat, Penny |
|
Bak: a Downstream Mediator of Fenretinide-induced Apoptosis of SH-SY5Y Neuroblastoma Cells |
| Lovat, Penny |
|
Fenretinide increases ceramide induction through acidic sphingomyelinase dependent hydrolysis of sphingomyelin resulting in downstream apoptosis of neuroblastoma cells |
| Lu, Xiaohong |
|
Identification of MYCN transcriptional activity inhibitors yields compounds which preferentially inhibit the growth of neuroblastoma cells |
| Lutz, Werner |
|
Role of Bmi1 in neuroblastoma |
| Malis, Josef |
|
Treatment results of high-risk neuroblastoma children (1995-2002). A single centre experience |
| Manetopoulos, Christina |
|
Comparative analysis of transcription factor function in pre B and neuroblastoma cells |
| Marchese, Nora |
|
Ibuprofen interferes with the capillary gas- chromatography determination of urinary HVA and VMA in Neuroblastoma diagnosis |
| Marimpietri, Danilo |
|
Antiangiogenic effects of chemotherapeutics, rapamycin and fenretinide in neuroblastoma |
| Maris, John |
|
Additional evidence for linkage of hereditary neuroblastoma to 16p13 and discovery of cooperating mutations |
| Maris, John |
|
Genome-wide transcriptome analysis for neuroblastoma gene discovery and refinement of clinical risk prediction |
| Maris, John |
|
Chromosome 11q deletions are an independent marker for decreased survival probability in patients with neuroblastoma: a Children’s Oncology Group Study |
| Maris, John |
|
High resolution detection of neuroblastoma hemi- and homo-zygous deletions with array-based comparative genomic hybridization (aCGH) |
| Marzi, Ilaria |
|
On the search of neuroblastoma stem cell compartment: electrophysiological and immunocytochemical studies |
| Massimo, Luisa |
|
Randomization and Informed Consent in Pediatric Oncology |
| Mastrangelo, Stefano |
|
Combinational Treatment with Chemotherapyt and 131-I-MIBG for Advanced Neuroblastoma at Diagnosis |
| Matthay, Katherine K |
|
131-I-MIBG double infusion with autologous stem cell transplant (ASCT) for neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) study |
| Matthay, Katherine K |
|
Neuroblastoma-associated Opsoclonus, Myoclonus, Ataxia syndrome: A Clinical and Biologic Dilemma |
| Matthias, Skowron |
|
Normalization to averaged expression levels of four control genes results in reliable transcript quantification by real-time RT-PCR in primary neuroblastoma |
| Mazanek, Pavel |
|
Assessment of P19/ARF-MDM-P53 and RAS pathways for alterations in neuroblastomas arising in the transgenic TH-MYCN mouse model |
| Mazzocco, Katia |
|
Biological studies on neuroblastoma (NB). Experience of the Italian Biology Reference Center |
| Mazzola, Cinzia |
|
Prospective analysis of complications central venous catheter related in paediatric patients with neuroblastoma. An experience of a single institution |
| McCluskey, Anthony |
|
[131I]meta-iodobenzylguanidine and Topotecan: Experimental Combination Treatment of Tumours Expressing the Noradrenaline Transporter |
| McConville, Carmel |
|
Multi-locus Alleotyping Defines Clinical Sub-types of Neuroblastoma |
| McKenzie, Pamela |
|
MYCN-Mediated Downregulation of p21Waf1/Cip1 Expression in Neuroblastoma |
| Meister, Bernhard |
|
Effects of recombinant TAT fusionprotein survivin T34A on neuroblastoma cells |
| Metelitsa, Leonid |
|
Natural Killer T Cells Infiltrate Metastatic Neuroblastomas Expressing The Chemokine CCL2/MCP-1 |
| Michalaowski, Mariana |
|
Tumor suppressor genes methylation in neuroblastoma: RASSF1 gene is almost always methyled in primary tumors |
| Ichikawa-Ohira, Miki |
|
Molecular signature to predict the prognosis of neuroblastoma and its application to a diagnostic microarray of clinical use |
| Milano, Giuseppe Maria |
|
Peculiar presentation of infant neuroblastoma: stage 4 or 4s? |
| Million, Karine |
|
Cisplatin induces p53 target genes expression independently of p73 in human neuroblastoma cells |
| Minturn, Jane |
|
Gene Expression Patterns in Neuroblastoma Cells Mediated by TrkA and TrkB Expression and Activation |
| Mitchell, Wendy G. |
|
Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia |
| Modak, Shakeel |
|
Single chain Fv-Streptavidin substantially improved therapeutic index in multi-step targeting directed at disialoganglioside GD2 |
| Modritz, Ditha |
|
Tumour Cell Clearing in the Bone Marrow of Stage 4 Neuroblastoma - Can it predict outcome? |
| Molenaar, Jan |
|
Inhibiting the Cyclin D1-pRb pathway in neuroblastoma |
| Mora, Jaume |
|
Gene expression profiling of neuroblastoma: analysis of nonmetastatic versus metastatic tumors |
| Mühlethaler, Annick |
|
TRAIL-induced apoptosis is fully restored in a caspase 8-complemented neuroblastoma cell line and is further enhanced by low doses of drugs via activation of intrinsic and extrinsic pathways |
| Muraji, Toshihiro |
|
An implication of TRK-A expression for surgical strategy in neuroblastoma |
| Myhre, Helena |
|
Docosahexaenoic acid potentiates the cytotoxic effect of chemotherapeutic drugs in neuroblastoma cells |
| Nakagawara, Akira |
|
Nuclear IkB kinase-alpha (IKK-alpha) regulates the proapoptotic function of p73, but not p53, during the cisplatin-mediated apoptosis |
| Nakagawara, Akira |
|
UFD2a, whose gene is localized in a 500 kb homozygously deleted region at chromosome 1p36.2 found in a neuroblastoma cell line, modulates p73 function through regulation of its stability |
| Nakagawara, Akira |
|
High expression of novel HECT-type E3 ubiquitin ligases, NEDL1 and NEDL2, which target Dishevelled-1 and p73, respectively, is associated with favorable neuroblastomas with spontaneous regression |
| Nakamura, Yohko |
|
BMP signaling in human neuroblastoma cells: the role of p27KIP1 and p53/p73 in inducing neuronal differentiation |
| Narath, Rita MSc |
|
Dramatic reduction of MYCN gene copy number and telomere lengths in F-cells induced by hydroxyurea |
| Narendran, Aru |
|
Studies Using 17-Allylamino-17-demethoxygeldanamycin (17-AAG) to Understand the Heterogeneity of Hsp90 Linked Survival and Signalling Pathways in Neuroblastoma |
| Navarro, Samuel |
|
Monoclonal antibody NB84 expression in the normal fetal sympathetic nervous system development and its relation with other neuroendocrine immunomarkers |
| Navarro, Samuel |
|
Prognostic impact of the International Neuroblastoma Pathology Classification (INPC) in Neuroblastoma (NB). The experience of the Spanish Neuroblastoma Registry |
| Negri, Francesca |
|
Immunocytological evaluation of bone marrow disease in peripheral neuroblastic tumours |
| Nelson, David |
|
NF-kB signalling in neuroblastoma cell survival |
| Nilsson, Helén |
|
Phenotypic changes in human neuroblastoma cells induced by oxygen and energy depletion |
| Norris, Murray D |
|
Establishment And Characterisation Of Cell Lines From MYCN Transgenic Murine Tumors |
| Norris, Murray D |
|
Expression Of Multidrug Transporter MRP4/ABCC4 Is A Marker Of Poor Prognosis In Neuroblastoma And Confers Resistance To Irinotecan In Vitro |
| Nurzyska-Flak, Joanna |
|
Incidence of neuroblastoma in the southeastern part of Poland |
| Oberthür, André |
|
The Tumor-Associated Antigen PRAME is universally expressed in high stage neuroblastoma and associated with poor outcome |
| Obexer, Petra |
|
FKHRL1 function in neuroblastoma cells |
| Obexer, Petra |
|
Tight regulation of retroviral gene expression by combination of advanced tetracycline-transactivator and repressor proteins |
| Oltra, Silvestre |
|
MAGE1 expression in primary tumor correlates with better outcome in Neuroblastoma patients |
| Oppenheimer, Orit |
|
Gene Expression Differences Among Stages in Stroma-Poor Neuroblastoma |
| Osone, Shinya |
|
Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells |
| Paffhausen, Tobias |
|
Sensitising effect of MYCN to different chemotherapeutic drugs in neuroblastoma cells |
| Palmberg, Ebba |
|
Continuous low-dose treatment with imatinib mesylate as a possible therapeutic concept for neuroblastoma |
| Park, Julie |
|
High risk stage 3 neuroblastoma: favorable outcome with myeloablative therapy and 13-cis-retinoic acid |
| Passoni, Lorena |
|
ALK kinase oncogenic potential in neuroblastoma cells |
| Pastorino, Fabio |
|
Anti-angiogenic effects of neuroblastoma tumour vessels-targeted liposomal chemotherapy |
| Pattyn, Filip |
|
Identification of relevant MYCN downstream effectors by a combinatorial multimodel approach |
| Peuchmaur, Michel |
|
Histoprognostic value of INPC classification in localised resectable neuroblastoma |
| Peylan-Ramu, Nili |
|
Overexpression of embryonal transcription factor OCT-3/4 in poor risk neuroblastoma |
| Pieper, Cornelia |
|
New advances in neuroblastoma minimal residual research: Five colour flow cytometry |
| Pike, Mike |
|
Opsoclonus-myoclonus (OMS): Diagnostic criteria and Neurological evaluation |
| Pike, Mike |
|
COG Therapeutic trial in OMS: A neurologist’s view |
| Pistoia, Vito |
|
Lymphoid infiltration in neuroblastoma-associated Opsoclonus Myoclonus Syndrome (OMS) |
| Podda, Marta |
|
Neuroblastoma (nbl) in adolescents and adults: analysis of a series of 33 consecutive patients |
| Ponthan, Frida |
|
Retinoids in Experimental Neuroblastoma Therapy |
| Prete, Arcangelo |
|
Immunotherapy with rHuIL-2 after autologous BMT for neuroblastoma |
| Raciborska, Anna |
|
Analysis of neuroblastoma treatment results of children between 1 and 2 years old in the aspect of moleculare, hystopathological and biochemical diagnostic markers |
| Raciborska, Anna |
|
Neuroblastoma in the first year of life. Analysis of one Institution in the period of 41 years |
| Raffaghello, Lizzia |
|
Functional expression and release of ligands for the activating immunoreceptor NKG2D in human neuroblastoma |
| Raffaghello, Lizzia |
|
Association of HLA class I antigen downregulation with multiple defects in antigen processing machinery components in human neuroblastoma |
| Raffaghello, Lizzia |
|
P2X7 receptor expression and function in human neuroblastoma |
| Raffaghello, Lizzia |
|
Involvement of CXCR4 in the development of neuroblastoma metastases |
| Raffaghello, Lizzia |
|
In vitro and in vivo antitumour activity of the synthetic polymer P10 |
| Raguenez, Gilda |
|
Wnt-5a gene expression in human metastatic malignant neuroblasts |
| Raguenez, Gilda |
|
Metastasis-associated genes in an experimental model of MYCN-amplified neuroblastoma |
| Reich, Adam |
|
Prognostic value of telomerase activity in neuroblastoma like tumours nostic value of telomerase activity in neuroblastoma like tumours |
| Revet, Ingrid |
|
MSX1: a target from the MEIS1 oncogene located on the 4p16 tumour suppressor region |
| Romani, Massimo |
|
Methylation Patterns in Ganglioneuroma and neuroblastoma |
| Romero, Maria |
|
Inhibition of apoptosis in Neuroblastoma cells by the bifunctional apoptosis regulator (BAR) |
| Ross, Robert |
|
Transdifferentiation underlies the development of cellular heterogeneity in human neuroblastoma cell lines |
| Rovigatti, Ugo |
|
Possible viral etiology in human neuroblastoma |
| Rubie, Hervè |
|
Localised and unresectable neuroblastoma in infants : Excellent outcome with low-dose primary chemotherapy. |
| Sagulenko, Vitaliya |
|
Genes Regulating Drug Sensitivity in Human Neurobalstoma |
| Sakai, Ryuichi |
|
Biological roles of hyperphosphorylated ShcC docking protein in neuroblastoma cells |
| Salcedo, Rosalba |
|
IL-27 mediates complete regression of primary and/or metastatic murine neuroblastoma tumors: role for CD8+ T cells |
| Sandoval, John |
|
Multiple Isoforms of PCNA in Neuroblastoma: Changes in structure, Changes in function? |
| Sato, Tomoyuki |
|
The role of Wnt signaling in neural crest (NC) development |
| Scaruffi, Paola |
|
Use of CGH array to identify MYCN amplification and chromosome 1P36 deletion in neuroblastoma |
| Scaruffi, Paola |
|
Identification of genes differently expressed in favorable and unfavorable histology neuroblastoma tumors |
| Schleiermacher, Gudrun |
|
Molecular cloning of unbalanced chromosome 17 breakpoints in neuroblastoma cell lines reveals distinct underlying mechanisms |
| Schramm, Alexander |
|
Prediction of Clinical Outcome and Biological Subclassification of Primary Neuroblastomas by Expression Profiling |
| Schroeder, Henrik |
|
Neuroblastoma in Denmark. A 20 years population based study |
| Schulte, Johanes |
|
Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells |
| Schumacher-Kuckelkorn, Roswitha |
|
GD2 loss variants in neuroblastoma |
| Seeger, Robert |
|
Chromogranin A (CGA), Tyrosine Hydroxylase (TH), and Protein Gene Product 9.5 (PGP9.5) Taqman( PCR Assays Improve Detection of Neuroblastoma Cells in Blood and Bone Marrow |
| Seeger, Robert |
|
Natural Killer (NK) Lymphocytes Are Cytotoxic for Multidrug Resistant Neuroblastoma Cells |
| Seeger, Robert |
|
Oligonucleotide Microarray Expression Profiles Identify Subsets of Patients with Ultra High- and High-Risk Metastatic Neuroblastoma |
| Sementa, Angela Rita |
|
Immunocytochemical detection of GD2-positive cells in bone marrow on diagnosis of localised neuroblastoma: clinical implications |
| Sholler, Giselle |
|
Regulation of Mitogenic Signaling by Nerve Growth Factor (NGF) and Brain-derived Neurotrophic Factor (BDNF) in Neuroblastoma cells |
| Shusterman, Suzanne |
|
Discovery of antiangiogenic targets for high-risk neuroblastoma using a high-density oligonucleotide-based approach |
| Sieverts, Hauke |
|
Expression of TrkA in SY5Y Neuroblastoma Cells Sensitizes for Chemotherapy-Induced Apoptosis by Up-Regulation of Caspase-8 |
| Simon, Thorsten |
|
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children >1 year with metastatic neuroblastoma |
| Simon, Thorsten |
|
New Definition of Low Risk Neuroblastoma Using Stage, Age, and 1p and MYCN Status |
| Slack, Andrew |
|
MDM2 is a Direct Target of the MYCN Oncogene in Neuroblastoma |
| Spano, Daniela |
|
Functional genomics in neuroblastoma |
| Spengler, Barbara |
|
I-like stem cells are indicators of malignancy of human neuroblastoma tumors |
| Spitz, Ruediger |
|
MYCN-Status according to FISH: Amplification, Gain, and Non-Amplification |
| Stockhausen, Marie |
|
Notch-1 signaling in neuroblastoma cells |
| Sugimoto, Tohru |
|
Treatment and prognostic factors of neuroblastoma in under 1-year-old infants in Japan |
| Svedmyr, Anders |
|
Anemia is a risk factor for cisplatin-induced hearing impairment in children with high-risk neuroblastoma |
| Swerts, Katrien |
|
Detection of residual neuroblastoma cells using a new four-color flow cytometric assay |
| Swerts, Katrien |
|
Detection of residual neuroblastoma cells using quantitative real-time RT-PCR |
| Swerts, Katrien |
|
Development and standardization of an immunocytochemical assay to detect residual neuroblastoma cells |
| Takita, Junko |
|
Gene expression profiling of neuroblastoma |
| Tanaka, Takeo |
|
Multivariate evaluation for heterogeneous neuroblastomas: the discrimination of progressing risk tumors detected clinically and through infantile mass-screening program |
| Tersak, Jean Marie |
|
Rituximab (anti-CD20) in the Treatment of Refractory Neuroblastoma Associated Opsoclonus-Myoclonus |
| Terui, Elena |
|
Shc Family Expression in Neuroblastoma |
| Thiele, Carol |
|
Targeting VEGF expression: Serum and/or IGF via the PI3kinase/mTor path stimulate HIF-1a and VEGF expression in Neuroblastoma (NB) |
| Thiele, Carol |
|
Transcriptional Therapy for Neuroblastoma (NB)- The HDAC inhibitors MS-275 and Depsipeptide decrease N-myc levels and inhibit NB tumor growth in vitro and in vivo |
| Thomas, Wayne |
|
Mechanisms of embryonal tumour initiation |
| Tomioka, Nobumoto |
|
Array comparative genomic hybridization (aCGH) defines genomic subgroups with a set of distinct aberrations which are strongly associated with the prognosis of patients with neuroblastoma |
| Tonelli, Roberto |
|
Anti-gene peptide nucleic acid (PNA) specifically and persistently blocks N-myc expression in neuroblastoma cells leading to cell-cycle inhibition and apoptosis |
| Tonini, Gian Paolo |
|
Somatic genetic events occurring in infant with neuroblastoma during the first year of life |
| Tornóczky, Tamàs |
|
Large cell neuroblastoma: A distinct type of neuroblastoma with aggressive clinical behavior |
| Tsuchida, Yoshiaki |
|
Effects of Human Endostatin on Neuroblastoma Xenograft: Lessons for Clinical Use |
| Tweddle, Deborah Anne |
|
Mismatch repair protein expression in pre and post treatment neuroblastoma |
| Twist, Clare |
|
Age contines to be a powerful predictor of EFS and OS in Neuroblastoma |
| Ushijima, Toshikazo |
|
Methylation of Multiple CpG Islands in Neuroblastomas with Poor Prognosis |
| Vadusevan, Sanjeev A |
|
NDSP, A Novel Secreted Protein in Neuroblastoma |
| Valent, Alexander |
|
Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors |
| Valentijn, Linda L.J. |
|
N-myc, Cdc42 and nm23 genes function in a differentiation pathway blocked by copy number defects in neuroblastoma |
| Valteau-Couanet, Dominique |
|
Results of NB 97 SFOP Protocol in children > 1 year with a stage 4 neuroblastoma |
| Van Roy, Frans |
|
A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts NBG1, a Putative Tumor Suppressor Gene |
| Van Roy, Nadine |
|
Interphase FISH reveals intratumoral heterogeneity of chromosome 17(q) status in neuroblastoma: implications for risk assessment |
| Vandesompele, Jo |
|
High-resolution Array-based Genomic Profiling of the Critical Region of Chromosome 17 Gain |
| Varesio, Luigi |
|
Response of neuroblastoma to the hypoxic environment |
| Veneselli, Edvidge |
|
Opsoclonus-myoclonus-ataxia with neuroblastoma. Follow-up of 7 cases. |
| Versteeg, Rogier |
|
The Delta-Notch pathway integrates the wnt pathway, the noradrenalin synthesis route and the neurotrophin pathway in neuroblastoma |
| Vicha, Ales |
|
CGH in chemoresistant neuroblastoma cell lines |
| Walton, Jeanette |
|
Characteristics of Stem Cell Clones from Human Neuroblastoma Cell Lines |
| Weber, Axel |
|
Coamplification of DDX1 Correlates with an Improved Survival Probability in Children with MYCN Amplified Human Neuroblastoma |
| Wechsler, Daniel |
|
Differential expression & regulation of MXI1 isoforms in neuroblastoma |
| Wei, Jun |
|
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma |
| Weiss, William |
|
Modifiers Of Tumor Susceptibility In A Mouse Model For Neuroblastoma |
| Westermann, Frank |
|
MYCN signalling pathways in vivo and in vitro |
| Westermann, Frank |
|
Combination of loss of heterozygosity and ploidy analysis clearly distinguishes between regions of allelic imbalance and allelic loss at 1p36 in neuroblastoma |
| White, Peter S |
|
Detailed Characterization of a 1p36.3 Region Consistently Deleted in Neuroblastoma |
| Wiedemeyer, Ruprecht |
|
Cell death-associated genes in neuroblastoma: evidence for a cell type-specific effect of ataxin-2 in doxorubicin-induced apoptosis |
| Wigginton, Jon |
|
Fluorescence-based Models for Imaging Alterations in the Growth, Metastasis, Angiogenesis and Apoptosis of Neuroblastoma Tumors |
| Wigginton, Jon |
|
IL-12 Inhibits AKT Activity And Induces BID Activation In Conjunction With Complete Regression Of Orthotopic Murine Neuroblastomas |
| Wigginton, Jon |
|
IL-18 Induces Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors and Potentiates Antitumor Immune Reactivity in Combination with IL-2 |
| Witt, Olaf |
|
The histone deacetylase inhibitor valproic acid activates a differentiation program in neuroblastoma cells |
| Witt, Volker |
|
Tumor cell detection in apheresis products in pediatric patients with advanced neuroblastoma – where to go? |
| Woo, Chan-Wook |
|
RNA Interference to elucidate the mechanism of cell cycle regulation by N-myc in neuroblastoma cells |
| Yamamoto, Keiko |
|
Neuroblastoma screening for older children |
| Yamashiro, Darrell |
|
ID2 promotes angiogenesis in neuroblastoma |
| Yamashiro, Darrell |
|
A pilot study of sequential myeloblative autologous stem cell transplantation (MA-AUTOSCT) and immunotherapy with reduced intensity allogenic stem cell transplant (RI-ALLOSCT) for high/risk neuroblastoma |
| Yang, Qi-Wei |
|
Association of Epigenetic Inactivation of RAS Association Domain Family Protein 1 (RASSF1A) with Poor Outcome in Human Neuroblastoma (NB) |
| Yang, Xuezhong |
|
Loss of hCas function, a novel neuroblastoma differentiation related gene, via LOH at chromosome 1p36.22 and functional silencing by N-myc |
| Yoneda, Akihiro |
|
Opsomyoclonus-ataxia syndrome occurred in regressing neuroblastoma detected through mass screening |
| Yu, Alice |
|
Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma |
| Zambrzycka, Izabella |
|
Inhibition of neuroblastoma cell proliferation by combination of STI-571 with 9-cis retinoic acid in vitro |
| Zanini, Cristina |
|
Proteomic and gene expression studies in neuroblastoma and Ewing sarcoma |
| Zanini, Cristina |
|
Flt-3 expression in neural crest-derived tissues and tumor cells |
| Zarri, Daniela |
|
Parents helping parents: do psychological mechanisms work when the child is affected by high risk neuroblastoma? |
| Zaucha-Prazmo, Agnieszka |
|
Megachemotherapy with auto HSCT in children with advanced neuroblastoma |
| Zawitkowska - Klaczynska, Joanna |
|
Outcome of Children with Neuroblastoma in the South-East Poland |
| Zawitkowska - Klaczynska, Joanna |
|
Neuroblastoma of paravertebral ganglions penetrating spinal canal - cases report |
| Zeng, Yan |
|
T-Cell mediated suppression of neuroblastoma following Fractalkine gene therapy is amplified by targeted IL-2 |
| Zimling, Zarah |
|
c-kit in neuroblastomas is not related to MYCN amplification |
| Zmora, Osnat |
|
Multidrug resistance in neuroblastoma cell lines is not associated with altered expression of ceramide pathway enzymes mRNA |
| Zollo, Massimo |
|
H-prune, nm23-H1 and nm23-H2: new markers of Neuroblastoma progression |